Beradio, Susana .
HRN: 01-23-38 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/16/2024
CEFTAZIDIME 1GM (VIAL)
04/16/2024
04/23/2024
IV
1gram
Q8hrs
CAP-MR; Recurrent Pleural Effusion
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes